ITGA4 and B-cell chronic lymphocytic leukemia: For example, ITGA4 overexpression in chronic lymphocytic leukemia (CLL) correlates with disease progression and high-risk biomarkers (56), while its low expression in colorectal cancer is linked to poor prognosis (57).